Article Details
Retrieved on: 2024-05-02 17:36:09
Tags for this article:
Click the tags to see associated articles and topics
Summary
Novartis is expanding in the biotech and pharmaceutical industry by acquiring Mariana Oncology, focusing on radiopharmaceuticals like Lutetium (177Lu) vipivotide tetraxetan to treat prostate cancer through advanced radiation therapy.
Article found on: www.statnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here